ENTX
Price
$1.19
Change
-$0.04 (-3.25%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
56.4M
51 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$15.04
Change
-$0.33 (-2.15%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
1.09B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENTX vs MLTX

Header iconENTX vs MLTX Comparison
Open Charts ENTX vs MLTXBanner chart's image
Entera Bio
Price$1.19
Change-$0.04 (-3.25%)
Volume$4.8K
Capitalization56.4M
MoonLake Immunotherapeutics
Price$15.04
Change-$0.33 (-2.15%)
Volume$42.33K
Capitalization1.09B
ENTX vs MLTX Comparison Chart in %
ENTX
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ENTX vs. MLTX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTX is a Hold and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ENTX: $1.23 vs. MLTX: $15.37)
Brand notoriety: ENTX and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTX: 177% vs. MLTX: 42%
Market capitalization -- ENTX: $56.4M vs. MLTX: $1.09B
ENTX [@Biotechnology] is valued at $56.4M. MLTX’s [@Biotechnology] market capitalization is $1.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTX’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • ENTX’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MLTX is a better buy in the long-term than ENTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTX’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • ENTX’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ENTX is a better buy in the short-term than MLTX.

Price Growth

ENTX (@Biotechnology) experienced а -20.65% price change this week, while MLTX (@Biotechnology) price change was -5.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

ENTX is expected to report earnings on Mar 27, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($1.09B) has a higher market cap than ENTX($56.4M). MLTX YTD gains are higher at: 16.616 vs. ENTX (-36.598). ENTX has higher annual earnings (EBITDA): -10.79M vs. MLTX (-227.94M). MLTX has more cash in the bank: 380M vs. ENTX (8.57M). ENTX has less debt than MLTX: ENTX (211K) vs MLTX (75.7M). ENTX has higher revenues than MLTX: ENTX (124K) vs MLTX (0).
ENTXMLTXENTX / MLTX
Capitalization56.4M1.09B5%
EBITDA-10.79M-227.94M5%
Gain YTD-36.59816.616-220%
P/E RatioN/AN/A-
Revenue124K0-
Total Cash8.57M380M2%
Total Debt211K75.7M0%
FUNDAMENTALS RATINGS
ENTX: Fundamental Ratings
ENTX
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTXMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 28 days ago
80%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 6 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ENTX
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDERX21.240.15
+0.71%
Federated Hermes Strategic Div Gr R
PASVX54.770.33
+0.61%
T. Rowe Price Small-Cap Value Adv
IVKSX21.960.02
+0.09%
VY® Invesco Comstock S
YOVIX17.69-0.17
-0.95%
Yorktown Small-Cap Institutional
NDXKX43.37-0.69
-1.57%
Shelton Nasdaq-100 Index K

ENTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTX has been loosely correlated with XENE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
-7.52%
XENE - ENTX
34%
Loosely correlated
+1.62%
JSPR - ENTX
32%
Poorly correlated
-2.04%
OPORF - ENTX
31%
Poorly correlated
N/A
MLTX - ENTX
30%
Poorly correlated
-2.66%
NGNE - ENTX
29%
Poorly correlated
-4.20%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-2.66%
KALA - MLTX
89%
Closely correlated
-10.84%
NEVPF - MLTX
70%
Closely correlated
N/A
IOBT - MLTX
60%
Loosely correlated
-0.58%
XNCR - MLTX
50%
Loosely correlated
-0.99%
NUVL - MLTX
48%
Loosely correlated
+2.12%
More